Skip to content

Immediate Mobilization After Cardiac Catheterisation

Patients Immediate Mobilization After Coronary Angiography and Percutaneous Coronary Intervention. Is it SAfe to MObilize Patients Very eARly After Cardiac Catheterisation?

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02069275
Acronym
SAMOVAR
Enrollment
2000
Registered
2014-02-24
Start date
2013-04-30
Completion date
2016-12-31
Last updated
2016-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comfort, Vascular Access Complication

Keywords

Immediate mobilization, Bedrest, Coronary angiography, Coronary percutaneous intervention, Vascular access complications, Patients comfort

Brief summary

The purpose of this study is to investigate the frequency of bleeding and haematomas in patients undergoing coronary angiography or percutaneous coronary intervention via femoral artery and mobilized immediately after the procedure, compared to those mobilized after two hours (following the standard regimen). At the same time the investigators will investigate whether it reduces the discomfort being mobilized immediately after the procedure.

Detailed description

The frequency of hematoma, bleeding or pseudoaneurysm at the access site in the groin is 7-15% with regimens that involve 0-2 hours of bed rest, somewhat more frequent after Percutaneous coronary intervention (PCI) than coronary angiography (CAG). There seems to be no reduction in the complications of the CAG or PCI by maintaining the bed rest for more than 2 hours after the procedure. Angio-Seal seems most effective of current closure devices. There is less discomfort associated with early compared with late mobilization. Protamine reverse heparin's effect without the side effects of that regime. There lacks a larger randomized study of the safety of mobilizing patients immediately after CAG and after PCI.

Interventions

Patients are mobilized immediate after coronary angiography and percutaneous coronary intervention via femoral access and closed with Angio-seal closing device. Heparin reverted with Protaminsulphate

OTHERTwo hours bedrest

Patients is following the usual regimen, two hours bedrest after coronary angiography and percutaneous coronary intervention via femoral access and closed with Angio-seal closing device before mobilization. Heparin is reverted with Protaminsulphate

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* CAG or PCI performed via the femoral artery * No hematoma in the groin (\> 5 cm in diameter) * Heparin reversed with protamine after PCI

Exclusion criteria

* Oozing, bleeding or hematoma * Treatment with Integrilin, ReoPro, or Marevan * Heparin can not be reversed * The patient does not want to participate * Systolic blood pressure \> 180 mm Hg after the procedure * BMI\> 35 (can be modified if the groin can be assessed in an upright position) * Demented, unconscious patients who do not understand the information for participants.

Design outcomes

Primary

MeasureTime frameDescription
Hematoma> 5 cmparticipants will be followed for the duration of hospital stay, an expected average of 24 hoursoccurred after the end of the procedure, including retroperitoneal hematoma, bleeding requiring transfusion or pseudoaneurysm that require vascular surgical intervention. Assessed after 30 minutes, after two hours and before discharge

Secondary

MeasureTime frame
The presence of hematoma> 10 cm in diameterparticipants will be followed for the duration of hospital stay, an expected average of 24 hours
The presence of hematoma 2-5 cm in diameterparticipants will be followed for the duration of hospital stay, an expected average of 24 hours
Oozing or bleeding from the puncture siteparticipants will be followed for the duration of hospital stay, an expected average of 24 hours
Comfort rating (NRS scale)Two hours after the procedure

Countries

Denmark

Contacts

Primary ContactMarianne W Noergaard, MVO
marianne.wetendorff.noergaard@regionh.dk+45 35458869
Backup ContactJane Faerch, MSc
jane.faerch.@regionh.dk+45 35452767

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026